According to PR Newswire, Synergy Life Science, Inc., a company in the health, wellness, and consumer goods industry, recently launched a water-based e-cigarette device called Nebi® in Atlanta, Georgia.
The product claims to use an advanced water-based platform utilizing cutting-edge ultrasonic technology to create safe water vapor without the need for heating or the use of e-liquid.
Chris Gerlach, the CEO of Synergy Life Science, stated:
We are excited to bring Nebi® to the vibrant market of Atlanta. Our goal is to provide a range of high-quality and truly safe e-cigarette products to local tobacco and e-cigarette shops to meet the diverse needs of customers.
According to reports, Synergy Life Science is an innovative company dedicated to consumer health, focusing on developing high-efficiency products by utilizing cannabis derivatives. The company mainly provides high-purity ingredients and groundbreaking technologies for the cannabis CBD market.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
